PX
53
3
SWKS
48
-7
LB
33
2
PNR
54
3
PAYX
41
5
PRU
60
-2
FITB
78
3
MTCH
70
11
CI
52
4
AVGO
35
-19
HON
68
-2
DUK
55
3
MPC
36
-2
IP
34
6
AAL
57
3
MDLZ
26
-2
LLY
84
13
LUV
70
2
CMS
60
2
FOXA
66
2
PX
53
3
SWKS
48
-7
LB
33
2
PNR
54
3
PAYX
41
5
PRU
60
-2
FITB
78
3
MTCH
70
11
CI
52
4
AVGO
35
-19
HON
68
-2
DUK
55
3
MPC
36
-2
IP
34
6
AAL
57
3
MDLZ
26
-2
LLY
84
13
LUV
70
2
CMS
60
2
FOXA
66
2
Financhill
Back

AtriCure, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
46

ATRC
AtriCure, Inc.

Last Price:
$41.35
Seasonality Move:
0.26%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$41.35
Seasonality Move:
0.59%
Sell
46
AtriCure, Inc. (ATRC) is a Sell

Is AtriCure, Inc. a Buy, Sell or Hold?

  • The current AtriCure, Inc. [ATRC] share price is $41.65. The Score for ATRC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ATRC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ATRC Stock Price Chart

What is AtriCure, Inc.'s stock price today?

  • The AtriCure, Inc. share price today is $41.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.63 Buy
Relative Strength Index (14 RSI): 64.51 Buy
Chaikin Money Flow: 188329 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.2 - 41.1) Buy
Bollinger Bands (100): (33.9 - 38.48) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

ATRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.22 Buy
20-day SMA: 39.19 Buy
50-day SMA: 36.49 Buy
200-day SMA: 34.32 Buy
8-day EMA: 40.83 Buy
20-day EMA: 39.29 Buy
50-day EMA: 37.32 Buy
200-day EMA: 35 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

AtriCure, Inc. Earnings Growth & ATRC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.11 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

AtriCure, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):